October 1, 2007

IDSA Announces New Board Members

The results are in! IDSA is pleased to announce the winners of this year’s election to the Board of Directors. They took positions on Saturday, Oct. 6, during the 45th Annual Meeting of IDSA in San Diego.

Vice President

Richard J. Whitley, MD, FIDSA, is the director of the division of pediatric infectious diseases and vice chair of the department of pediatrics at the University of Alabama at Birmingham. Dr. Whitley was previously chair of IDSA’s Annual Meeting Program Committee. He served on the editorial board for the Journal of Infectious Diseases(JID) and was chair of the JID Editor Selection Committee.


William Schaffner, MD, FIDSA, is professor and chairman of the Department of Preventive Medicine and professor of medicine in the Division of Infectious Diseases at Vanderbilt University School of Medicine. He has served as hospital epidemiologist at Vanderbilt University Hospital for nearly 30 years and is an active member of 20 professional societies. He has served on various IDSA committees including the Awards Committee, the Public Policy Committee, and the JID Editor Selection Committee. He chaired the IDSA Public Health/Preventive Medicine Committee and is a founding member of the Tennessee Infectious Diseases Society.


Stephen B. Calderwood, MD, FIDSA, is professor and chief of the division of infectious diseases at Massachusetts General Hospital. He has served on IDSA’s ID Training Program Directors Committee, the Board of State and Regional Societies, and the Education Committee, and was chair of the ID Training Program Directors Committee.

Sandra A. Kemmerly, MD, FIDSA, is associate chair of infectious diseases at Ochsner Medical Center, medical director of Ochsner Health System, and clinical assistant professor of medicine at Louisiana State University School of Medicine. She has served on the IDSA Clinical Affairs Committee and the Annual Meeting Program Committee. Dr. Kemmerly is a member of the Louisiana/Mississippi Infectious Diseases Society Board and currently serves as an abstract reviewer for the IDSA Annual Meeting.

HIVMA Representative

Daniel R. Kuritzkes, MD, FIDSA, is associate professor of medicine at Harvard Medical School and director of AIDS research at Brigham and Women's Hospital. He is also head of the Section of Retroviral Therapeutics for the Harvard Division of AIDS and principal investigator of the Harvard Adult AIDS Clinical Trials Unit. He has served on the HIVMA Board of Directors, the National Institutes of Health AIDS Research Review Committee, and has been an associate editor of JID since 2002.

< Previous Article | Next Article >

Thinking Outside the Box
ART, Circumcision, STI Treatment as HIV Prevention
Global Surveillance, Vaccine Use Key to Controlling Seasonal Influenza
Bad Bugs on the Run
IDSA Advocacy Update
HIV PrEP: Should We or Shouldn’t We?
Keep Up with Drug Approvals, Recalls, Adverse Events
Lyme Disease: When Symptoms Don’t Improve
Alternative Approaches, Possible Vaccines Against MRSA Infections
New Hope for Viral Suppression in All HIV Patients
Resistant Staph: Use One Drug or a Combination?
Congratulations to the 2007 Society Award Recipients
Winners of the 2007 IDSA/SHEA Advancements in MRSA Awards
Congratulations to This Year’s 50 Outstanding Scholars!
IDSA Announces New Board Members
Welcome, New IDSA Members!
Electronic Tools for Infectious Diseases Practitioners
From the President
Public Reporting of HAIs May Have Unintended Consequences
Treatment Options for C. difficile
XDR TB: Where it Came From, Where We’re Going
Search Back Issues
Forward this Issue
Print-Friendly Version

© Copyright IDSA 2008 Infectious Diseases Society of America 1300 Wilson Boulevard, Suite 300 Arlington, VA 22209 info@idsociety.org

Home Page Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA